Impact of TP53 Gain-of-Function Mutations on Metabolic Reprogramming in Prostate Cancer Progression
Farida Jazuli Usman, Dikshat Gopal Gupta, Sarki A Abdulkadir, Ibrahim Muhammad Usman, Adamu Jibrin Alhassan, Young A Yoo, Haris Jaafar Bello, Binta G. Kurfi & Kamaluddeen Babagana · Asian Journal of Biochemistry, Genetics and Molecular Biology · 2025
Despite advancements in the treatment of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC), the disease remains lethal, often developing resistance to conventional therapies such as androgen deprivation therapy (ADT) and chemotherapy. The...
Open access
Research Article
10.9734/ajbgmb/2025/v17i1434